Please ensure Javascript is enabled for purposes of website accessibility
Accessibility Menu
Danaher Stock Quote

Danaher (NYSE: DHR)

$239.39
(-0.4%)
-$0.95
Price as of April 17, 2024, 4:00 p.m. ET

Danaher Return vs. S&P

1 Year 5 Year 5 Year Annualized Since IPO
DHR +6.50% +118.23% +16.89% +68,067%
S&P +21.68% +73.88% +11.70% +5,451%

Danaher Company Info

Danaher Corp. engages in the design, manufacture, and marketing of professional, medical, industrial, and commercial products and services. It operates through the following segments: Biotechnology, Life Sciences, Diagnostics, and Environmental and Applied Solutions. The Biotechnology segment includes the bioprocessing and discovery and medical businesses and offers a range of tools, consumables, and services. The Life Sciences segment offers a range of instruments and consumables to study the basic building blocks of life, including DNA and RNA. The Diagnostics segment offers clinical instruments, reagents, consumables, software, and services used to diagnose disease and make treatment decisions. The Environmental and Applied Solution segment offers products and services that help protect important resources and keep global food and water supplies safe. The company was founded by Steven M. Rales and Mitchell P. Rales in 1984 and is headquartered in Washington, DC.

News & Analysis

The Fool has written over 200 articles on Danaher.

Valuation

Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.